These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2527543

  • 1. The influence of cilazapril on indices of autonomic function in normotensives and hypertensives.
    Elliott HL, Ajayi AA, Reid JL.
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):303S-307S. PubMed ID: 2527543
    [Abstract] [Full Text] [Related]

  • 2. The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension.
    Ajayi AA, Elliott HL, Reid JL.
    Br J Clin Pharmacol; 1986 Aug; 22(2):167-75. PubMed ID: 3019375
    [Abstract] [Full Text] [Related]

  • 3. Alpha-adrenergic and angiotensin II pressor sensitivity in hypertensive patients treated with an angiotensin-converting enzyme inhibitor.
    Rosendorff C, Patton J, Radford HM, Kalliatakis B.
    J Cardiovasc Pharmacol; 1992 Aug; 19 Suppl 6():S105-9. PubMed ID: 1382157
    [Abstract] [Full Text] [Related]

  • 4. Cilazapril inhibits vascular responses to baroreflex-stimulated sympathetic neural activity in hypertensive patients.
    Fernandez PG, Bolli P, Lee C, Vasdev S.
    Can J Cardiol; 1990 Aug; 6(1):9-14. PubMed ID: 2138049
    [Abstract] [Full Text] [Related]

  • 5. Renin-angiotensin modulation of sympathetic reflex function in essential hypertension and in the elderly.
    Ajayi AA, Reid JL.
    Int J Clin Pharmacol Res; 1988 Aug; 8(5):327-33. PubMed ID: 2852643
    [Abstract] [Full Text] [Related]

  • 6. Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
    Kleinbloesem CH, Erb K, Essig J, Breithaupt K, Belz GG.
    Br J Clin Pharmacol; 1989 Aug; 27 Suppl 2(Suppl 2):309S-315S. PubMed ID: 2527544
    [Abstract] [Full Text] [Related]

  • 7. Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.
    Belz GG, Essig J, Kleinbloesem CH, Hoogkamer JF, Wiegand UW, Wellstein A.
    Br J Clin Pharmacol; 1988 Nov; 26(5):547-56. PubMed ID: 2974715
    [Abstract] [Full Text] [Related]

  • 8. The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen.
    Fernandez PG, Bolli P, Lee C.
    Can J Cardiol; 1990 Mar; 6(2):53-8. PubMed ID: 2138051
    [Abstract] [Full Text] [Related]

  • 9. Does the combination of cilazapril and propranolol lower blood pressure at rest and during exercise more pronouncedly than either of the two components given alone?
    Erb KA, Breithaupt K, Kleinbloesem CH, Wolf GK, Belz GG.
    Clin Physiol Biochem; 1990 Mar; 8 Suppl 2():35-45. PubMed ID: 2151315
    [Abstract] [Full Text] [Related]

  • 10. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
    Gasic S, Heinz G, Kleinbloesem C, Korn A.
    Br J Clin Pharmacol; 1989 Mar; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular pressor reactivity after chronic converting enzyme inhibition.
    Bernasconi M, Marone C, Beretta-Piccoli C, Lepori G, Shaw S, Weidmann P.
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):348-55. PubMed ID: 1829371
    [Abstract] [Full Text] [Related]

  • 12. Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure.
    Binkley PF, Nunziata E, Haas GJ, Starling RC, Leier CV, Cody RJ.
    Am Heart J; 2000 Jul; 140(1):34-42. PubMed ID: 10874261
    [Abstract] [Full Text] [Related]

  • 13. Effects on autonomic function of a new angiotensin converting enzyme inhibitor, ramipril.
    Sugimoto K, Kumagai Y, Tateishi T, Seguchi H, Ebihara A.
    J Cardiovasc Pharmacol; 1989 Jul; 13 Suppl 3():S40-4. PubMed ID: 2474100
    [Abstract] [Full Text] [Related]

  • 14. The effects of the long-acting angiotensin-converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure.
    White WB, McCabe EJ, Hager WD, Schulman P.
    Clin Pharmacol Ther; 1988 Aug; 44(2):173-8. PubMed ID: 2969315
    [Abstract] [Full Text] [Related]

  • 15. The effects of antihypertensive medications on the physiological response to maximal exercise testing.
    Derman WE, Sims R, Noakes TD.
    J Cardiovasc Pharmacol; 1992 Aug; 19 Suppl 5():S122-7. PubMed ID: 1381788
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and effects on renal function following cilazapril and hydrochlorothiazide alone and in combination in healthy subjects and hypertensive patients.
    Nilsen OG, Sellevold OF, Romfo OS, Smedsrud A, Grynne B, Williams PE, Kleinbloesem CH.
    Br J Clin Pharmacol; 1989 Aug; 27 Suppl 2(Suppl 2):323S-328S. PubMed ID: 2527546
    [Abstract] [Full Text] [Related]

  • 17. Effects of chronic cilazapril treatment on cardiovascular control: a spectral analytical approach.
    Pagani M, Pizzinelli P, Mariani P, Lucini D, di Michele R, Malliani A.
    J Cardiovasc Pharmacol; 1992 Aug; 19 Suppl 6():S110-6. PubMed ID: 1382158
    [Abstract] [Full Text] [Related]

  • 18. Comparative evaluation of the acute and chronic effects of cilazapril and hydrochlorothiazide on diastolic cardiac function in hypertensive patients.
    Schneeweiss A, Rosenthal J, Marmor A.
    J Hum Hypertens; 1990 Oct; 4(5):535-9. PubMed ID: 2149388
    [Abstract] [Full Text] [Related]

  • 19. A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor.
    Waterfall JF.
    Br J Clin Pharmacol; 1989 Oct; 27 Suppl 2(Suppl 2):139S-150S. PubMed ID: 2527528
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of angiotensin-I response by cilazapril and its time course in normal volunteers.
    Wellstein A, Essig J, Belz GG.
    Clin Pharmacol Ther; 1987 Jun; 41(6):639-44. PubMed ID: 3034469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.